Response to Comment on Beltrand et al. Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations. Diabetes Care 2015;38:2033-2041

Diabetes Care. 2016 Sep;39(9):e155. doi: 10.2337/dci16-0002.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus
  • Humans
  • Mutation
  • Potassium Channels / genetics*
  • Potassium Channels, Inwardly Rectifying / genetics
  • Sulfonylurea Compounds*

Substances

  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Sulfonylurea Compounds